secwatch / observer
8-K filed January 31, 2024, 6:59 PM ET ticker HSCS CIK 0001468492
regulatory confidence high sentiment negative materiality 0.60

HeartSciences Inc. (HSCS): Nasdaq/NYSE listing notice — Heart Test Labs gets 180-day Nasdaq bid-price extension; faces delisting if not compliant by July 29, 2024

HeartSciences Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

HeartSciences Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

Exchange
nasdaq
Notice
extension granted
Deficiency
minimum bid price
Rules
5810(c)(3)(A)
Exact text from the filing
January 30, 2024, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day extension to July 29, 2024, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If the Company does not regain compliance within the allotted compliance period, Nasdaq staff will provide notice that the Company’s Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. The Company will continue to monitor the closing bid price of it
View on SEC.gov

Browse all listing & compliance notices →

HeartSciences Inc. filing history →

Source: SEC EDGAR
accession 0000950170-24-009160
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.